Notice of Intent to Sole Source – Cardinal Health, Inc.
Closed Special Notice Posted
- Solicitation number
- 25-003394
- Agency
-
NIH Clinical Center
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 339112 Surgical and Medical Instrument Manufacturing
- Place of performance
- bethesda, Maryland 20892, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institutes of Health (NIH) Clinical Center has issued a Special Notice of Intent to Sole Source a fixed price purchase order to Cardinal Health, Inc. for Floxuridine Vials used in patient care. The notice, posted on January 17, 2025, with a response deadline of March 5, 2025, outlines the agency's intention to award a contract directly to Cardinal Health. The procurement will be conducted under Federal Acquisition Regulation (FAR) Part 13 - Simplified Acquisition Procedures, which allows for single-source procurement when only one source is reasonably available. Cardinal Health is identified as the sole distributor of this specific medication in the United States, justifying the direct award approach.
The primary objective of this Special Notice is to inform potential contractors about NIH's intent to award a sole source contract for Floxuridine Vials, with a specific quantity of 10 units. Interested parties have the opportunity to demonstrate their interest and capabilities in response to the notice by submitting comments to Kristin Nagashima, Contract Specialist, via email to Kristin.nagashima@nih.gov by February 10th, 2025 at 4pm EST. The government retains sole discretion in determining whether to compete the requirement based on responses received. The contract will be awarded using FAR Part 13 Simplified Acquisition Procedures, which exempts the procurement from standard competition requirements. Contractors should note that while they may express interest, the ultimate decision rests with the NIH Clinical Center's contracting team, and no solicitation document will be issued as part of this notice.
Notice text
3 versions
Update #3 · Latest ·
This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested.
The National Institutes of Health (NIH) intends to award a fixed price purchase order to Cardinal Health, Inc, located at 7000 Cardinal Pl, Dublin, OH 43017, on a firm fixed price sole source award basis to provide Floxuridine Vials for patient care to the National Institutes of Health.
Below is a description of the item(s):
Description: Floxuridine for Injection
Catalog #: 0143-9270-01
Units: EACH
Quantity: 10
The proposed vendor, Cardinal Health, Inc, is the only source that distributes this medication in the United States.
This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 – Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT), contracting officers may solicit from one source if the contracting officer determines that the circumstance of the contract action deem only one source reasonably available. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements. Interested parties may identify their interest and capabilities in response to this posting. The determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government.
Comments to this announcement, referencing this posting number, may be submitted to the NIH, Clinical Center, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, to the attention of Kristin Nagashima, Contract Specialist via email to Kristin.nagashima@nih.gov by March 5th, 2025 at 11am EST.
Update #2 ·
This notice has been cancelled as of Janurary 23rd, 2025 at 1:36pm EST.
This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested.
The National Institutes of Health (NIH) intends to award a fixed price purchase order to Cardinal Health, Inc, located at 7000 Cardinal Pl, Dublin, OH 43017, on a firm fixed price sole source award basis to provide Floxuridine Vials for patient care to the National Institutes of Health.
Below is a description of the item(s):
Description: Floxuridine for Injection
Catalog #: 0143-9270-01
Units: EACH
Quantity: 10
The proposed vendor, Cardinal Health, Inc, is the only source that distributes this medication in the United States.
This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 – Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT), contracting officers may solicit from one source if the contracting officer determines that the circumstance of the contract action deem only one source reasonably available. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements. Interested parties may identify their interest and capabilities in response to this posting. The determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government.
Comments to this announcement, referencing this posting number, may be submitted to the NIH, Clinical Center, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, to the attention of Kristin Nagashima, Contract Specialist via email to Kristin.nagashima@nih.gov by February 10th, 2025 at 4pm EST.
Update #1 ·
This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested.
The National Institutes of Health (NIH) intends to award a fixed price purchase order to Cardinal Health, Inc, located at 7000 Cardinal Pl, Dublin, OH 43017, on a firm fixed price sole source award basis to provide Floxuridine Vials for patient care to the National Institutes of Health.
Below is a description of the item(s):
Description: Floxuridine for Injection
Catalog #: 0143-9270-01
Units: EACH
Quantity: 10
The proposed vendor, Cardinal Health, Inc, is the only source that distributes this medication in the United States.
This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 – Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT), contracting officers may solicit from one source if the contracting officer determines that the circumstance of the contract action deem only one source reasonably available. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements. Interested parties may identify their interest and capabilities in response to this posting. The determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government.
Comments to this announcement, referencing this posting number, may be submitted to the NIH, Clinical Center, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, to the attention of Kristin Nagashima, Contract Specialist via email to Kristin.nagashima@nih.gov by February 10th, 2025 at 4pm EST.
Similar open opportunities
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity